Jul. 3 at 8:27 PM
$MBOT anyways, not many people have heard of microbot yet and because it is speculative until FDA approval, it is severely undervalued. Dig into the company, there were some other things going on with it in the past that have nothing to due with the current c-suite and company focus.
Basically, prior to the last 5 years is irrelevant and since 2019 the liberty product has gone from prototype to approaching the finish line of FDA approval.
basic fundamentals of market cap are undeniable. i see no drawbacks of the liberty system. if anybody can tell me why this won't be standard in all hospitals in the next decade please let me know in the comments. this is easily a 5 billion company meaning its worth 130 in todays share float of 37million or 83 at a full allowed 60 million float.
the company has been very conservative in share offerings, staying listed and is making alot of good moves tactically in the run up to approval
happy independence day! Freedom! Liberty!
